Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino

Detalhes bibliográficos
Autor(a) principal: Toffoletto, Odaly
Data de Publicação: 2005
Outros Autores: Tavares, Agostinho [UNIFESP], Casarini, Dulce Elena [UNIFESP], Redublo, Beata Marie [UNIFESP], Ribeiro, Artur Beltrame [UNIFESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S1413-78522005000500005
http://repositorio.unifesp.br/handle/11600/2384
Resumo: Osteoarthrosis is a chronic joint disease that, once patent, leads to a progressive functional disability. As proteochondroitin sulfates are the major contents of the cartilage, it is expected that the ingestion of glucosamine and chondroitin might improve the biological status of that tissue. As we could not find any studies on the pharmacokinetic profile of this association by oral administration route in human beings, the objective of this study was to evaluate it by using the association of glucosamine sulfate (GS) and chondroitin sulfate (CS) given to two groups of twelve healthy male volunteers (group I: one capsule containing 500 mg of GS and 400 mg of CS; group II: four capsules with the same content). Blood samples were collected at pre-determined time intervals up to 48 hours post-dosing. GS and CS were measured in plasma by the DMMB (1,9,dimethyl-dimethilene blue) method. Maximum concentration was achieved within 2 hours (average ± SE; 0.893±0.093 µg/ml, group I; and 2.222±0.313 µg/ml, group II). Areas under curve up to 48 hours were 10.803±0.965 µg-hr/ml and 38.776±2.981 µg-hr/ml for groups I and II, respectively. Both groups showed a second peak after 18 hours, indicating an enterohepatic flow. Our results indicate that this association is absorbed through the oral route by a saturable mechanism, which can enable its use in clinical treatments.
id UFSP_c1d2729622641aef300b8202c25f276b
oai_identifier_str oai:repositorio.unifesp.br/:11600/2384
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculinoPharmacokinetic profile of glucosamine and chondroitin sulfate association in healthy male individualsOsteoarthrosisChondroitin SulfateGlucosamineProteoglicansOsteoartroseSulfato de condroitinaGlucosaminaProteoglicanosOsteoarthrosis is a chronic joint disease that, once patent, leads to a progressive functional disability. As proteochondroitin sulfates are the major contents of the cartilage, it is expected that the ingestion of glucosamine and chondroitin might improve the biological status of that tissue. As we could not find any studies on the pharmacokinetic profile of this association by oral administration route in human beings, the objective of this study was to evaluate it by using the association of glucosamine sulfate (GS) and chondroitin sulfate (CS) given to two groups of twelve healthy male volunteers (group I: one capsule containing 500 mg of GS and 400 mg of CS; group II: four capsules with the same content). Blood samples were collected at pre-determined time intervals up to 48 hours post-dosing. GS and CS were measured in plasma by the DMMB (1,9,dimethyl-dimethilene blue) method. Maximum concentration was achieved within 2 hours (average ± SE; 0.893±0.093 µg/ml, group I; and 2.222±0.313 µg/ml, group II). Areas under curve up to 48 hours were 10.803±0.965 µg-hr/ml and 38.776±2.981 µg-hr/ml for groups I and II, respectively. Both groups showed a second peak after 18 hours, indicating an enterohepatic flow. Our results indicate that this association is absorbed through the oral route by a saturable mechanism, which can enable its use in clinical treatments.A osteoartrose é uma doença crônica das articulações que, uma vez instalada, leva seus portadores a uma incapacidade funcional progressiva. Como os proteocondroitins sulfato são os maiores constituintes das cartilagens, espera-se que com a ingestão de glucosamina e condroitina haja uma melhora das condições biológicas desse tecido. Uma vez que não temos conhecimento de estudo da farmacocinética da administração oral dessa associação em seres humanos, o objetivo deste trabalho foi avaliá-la utilizando a associação entre o sulfato de glucosamina (SG) e o sulfato de condroitina (SC) administrada a dois grupos de doze voluntários sadios do sexo masculino (grupo I uma cápsula de (500 mg SG; 400 mg SC) e grupo II quatro cápsulas). Amostras de sangue foram retiradas a intervalos de tempo pré-definidos até 48 horas pós-dose. O SG e o SC foram dosados no plasma pelo método de DMMB (azul de 1,9,dimetildimetileno). A concentração máxima foi atingida em 2 horas (média ±SE; 0,893±0,093 µg/mL, grupo I e 2,222±0,313 µg/mL, grupo II). As áreas sob a curva até 48 horas foram de 10,803±0,965 µg-hr/mL e 38,776±2,981 µg-hr/mL, respectivamente para os grupos I e II. Os dois grupos apresentaram um segundo pico após 18 horas, indicando circulação êntero-hepática. Os nossos resultados indicam que essa associação é absorvida por via oral por mecanismo saturável, o que pode facilitar o seu uso em tratamentos clínicos.Fundação Oswaldo Ramos Hospital do Rim e HipertensãoUNIFESP-EPMUNIFESP, EPMSciELOSociedade Brasileira de Ortopedia e TraumatologiaFundação Oswaldo Ramos Hospital do Rim e HipertensãoUniversidade Federal de São Paulo (UNIFESP)Toffoletto, OdalyTavares, Agostinho [UNIFESP]Casarini, Dulce Elena [UNIFESP]Redublo, Beata Marie [UNIFESP]Ribeiro, Artur Beltrame [UNIFESP]2015-06-14T13:31:25Z2015-06-14T13:31:25Z2005-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion235-237application/pdfhttp://dx.doi.org/10.1590/S1413-78522005000500005Acta Ortopédica Brasileira. Sociedade Brasileira de Ortopedia e Traumatologia, v. 13, n. 5, p. 235-237, 2005.10.1590/S1413-78522005000500005S1413-78522005000500005.pdf1413-7852S1413-78522005000500005http://repositorio.unifesp.br/handle/11600/2384porActa Ortopédica Brasileirainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-28T08:22:01Zoai:repositorio.unifesp.br/:11600/2384Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-28T08:22:01Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
Pharmacokinetic profile of glucosamine and chondroitin sulfate association in healthy male individuals
title Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
spellingShingle Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
Toffoletto, Odaly
Osteoarthrosis
Chondroitin Sulfate
Glucosamine
Proteoglicans
Osteoartrose
Sulfato de condroitina
Glucosamina
Proteoglicanos
title_short Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
title_full Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
title_fullStr Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
title_full_unstemmed Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
title_sort Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
author Toffoletto, Odaly
author_facet Toffoletto, Odaly
Tavares, Agostinho [UNIFESP]
Casarini, Dulce Elena [UNIFESP]
Redublo, Beata Marie [UNIFESP]
Ribeiro, Artur Beltrame [UNIFESP]
author_role author
author2 Tavares, Agostinho [UNIFESP]
Casarini, Dulce Elena [UNIFESP]
Redublo, Beata Marie [UNIFESP]
Ribeiro, Artur Beltrame [UNIFESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Fundação Oswaldo Ramos Hospital do Rim e Hipertensão
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Toffoletto, Odaly
Tavares, Agostinho [UNIFESP]
Casarini, Dulce Elena [UNIFESP]
Redublo, Beata Marie [UNIFESP]
Ribeiro, Artur Beltrame [UNIFESP]
dc.subject.por.fl_str_mv Osteoarthrosis
Chondroitin Sulfate
Glucosamine
Proteoglicans
Osteoartrose
Sulfato de condroitina
Glucosamina
Proteoglicanos
topic Osteoarthrosis
Chondroitin Sulfate
Glucosamine
Proteoglicans
Osteoartrose
Sulfato de condroitina
Glucosamina
Proteoglicanos
description Osteoarthrosis is a chronic joint disease that, once patent, leads to a progressive functional disability. As proteochondroitin sulfates are the major contents of the cartilage, it is expected that the ingestion of glucosamine and chondroitin might improve the biological status of that tissue. As we could not find any studies on the pharmacokinetic profile of this association by oral administration route in human beings, the objective of this study was to evaluate it by using the association of glucosamine sulfate (GS) and chondroitin sulfate (CS) given to two groups of twelve healthy male volunteers (group I: one capsule containing 500 mg of GS and 400 mg of CS; group II: four capsules with the same content). Blood samples were collected at pre-determined time intervals up to 48 hours post-dosing. GS and CS were measured in plasma by the DMMB (1,9,dimethyl-dimethilene blue) method. Maximum concentration was achieved within 2 hours (average ± SE; 0.893±0.093 µg/ml, group I; and 2.222±0.313 µg/ml, group II). Areas under curve up to 48 hours were 10.803±0.965 µg-hr/ml and 38.776±2.981 µg-hr/ml for groups I and II, respectively. Both groups showed a second peak after 18 hours, indicating an enterohepatic flow. Our results indicate that this association is absorbed through the oral route by a saturable mechanism, which can enable its use in clinical treatments.
publishDate 2005
dc.date.none.fl_str_mv 2005-01-01
2015-06-14T13:31:25Z
2015-06-14T13:31:25Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S1413-78522005000500005
Acta Ortopédica Brasileira. Sociedade Brasileira de Ortopedia e Traumatologia, v. 13, n. 5, p. 235-237, 2005.
10.1590/S1413-78522005000500005
S1413-78522005000500005.pdf
1413-7852
S1413-78522005000500005
http://repositorio.unifesp.br/handle/11600/2384
url http://dx.doi.org/10.1590/S1413-78522005000500005
http://repositorio.unifesp.br/handle/11600/2384
identifier_str_mv Acta Ortopédica Brasileira. Sociedade Brasileira de Ortopedia e Traumatologia, v. 13, n. 5, p. 235-237, 2005.
10.1590/S1413-78522005000500005
S1413-78522005000500005.pdf
1413-7852
S1413-78522005000500005
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Acta Ortopédica Brasileira
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 235-237
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Ortopedia e Traumatologia
publisher.none.fl_str_mv Sociedade Brasileira de Ortopedia e Traumatologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268397114884096